About Bioatrix
Bioatrix is a Healthcare company based in Sydney (Australia) founded in 2012, and was acquired by ZZ Biotech in January 2016. Developing activated protein C (aPC)-based products primarily for wound healing. The company was acqui-hired. Its focus areas include Life Sciences, Wound Care and Drugs.
Company details
Bioatrix is a regenerative medicine company primarily focussed on developing protein-based products for wound healing. It has licensed the technology based on the Activated Protein C (aPC) from the Sydney University. These proteins claim to have shown potential as a treatment for inflammatory skin diseases, such as psoriasis and eczema, and hypertrophic scarring. The company is currently working on phase 2 trials wound healing. In December 2015, ZZ Biotech acquired Bioatrix and since then it is working as its subsidiary.
- Headquarters Sydney, Australia
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website bioatrix.com
- Acquired by ZZ Biotech (Jan 2016)
- Investors
- Acquired byZZ Biotech
(Jan 2016)
Investors in Bioatrix
Bioatrix has secured backing from 1 investor. Prominent investors backing the company include ZZ Biotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Genetically engineered proteins for stroke and brain disorders are developed. | 2006 | zzbiotech.com | Houston, United States |
Investor details for Bioatrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioatrix
2 dated milestones of Bioatrix across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Bioatrix is founded.
- Exit Acquired by ZZ Biotech.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioatrix
Bioatrix was founded in 2012.
Bioatrix is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Bioatrix is a regenerative medicine company primarily focussed on developing protein-based products for wound healing. It has licensed the technology based on the Activated Protein C (aPC) from the Sydney University. These proteins claim to have shown potential as a treatment for inflammatory skin diseases, such as psoriasis and eczema, and hypertrophic scarring. The company is currently working on phase 2 trials wound healing. In December 2015, ZZ Biotech acquired Bioatrix and since then it is working as its subsidiary.
Bioatrix has 1 investor. Key investors include ZZ Biotech.
Yes. Bioatrix was acquired by ZZ Biotech in January 2016.